{
    "200_day_moving_avg": {
        "title": "200-Day Moving Average",
        "value": "7.03"
    },
    "50_day_moving_avg": {
        "title": "50-Day Moving Average",
        "value": "7.04"
    },
    "52_week_change": {
        "title": "52-Week Change",
        "value": "-6.61%"
    },
    "52_week_high": {
        "title": "52 Week High",
        "value": "12.48"
    },
    "52_week_low": {
        "title": "52 Week Low",
        "value": "5.61"
    },
    "company_name": {
        "title": "Company Name",
        "value": "Longeveron Inc. (LGVN)"
    },
    "float": {
        "title": "Float",
        "value": "N/A"
    },
    "fullTimeEmployees": {
        "title": "Profile",
        "value": 12
    },
    "held_by_insiders": {
        "title": "% Held by Insiders",
        "value": "255.87%"
    },
    "held_by_institutions": {
        "title": "% Held by Institutions",
        "value": "0.00%"
    },
    "industry": {
        "title": "Industry",
        "value": "Biotechnology"
    },
    "profile": {
        "title": "Profile",
        "value": "Longeveron Inc., a clinical stage biotechnology company, engages in developing cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications comprising aging frailty, alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida."
    },
    "sector": {
        "title": "Sector",
        "value": "Healthcare"
    },
    "shares_outstanding": {
        "title": "Shares Outstanding",
        "value": "3.25M"
    },
    "shares_short": {
        "title": "Shares Short (Mar 15, 2021)",
        "value": "185.28k"
    },
    "short_percent_of_float": {
        "title": "Short % of Float (Mar 15, 2021)",
        "value": "5.82%"
    },
    "short_percent_of_shares_outstanding": {
        "title": "Short % of Shares Outstanding (Mar 15, 2021)",
        "value": "0.98%"
    },
    "short_ratio": {
        "title": "Short Ratio (Mar 15, 2021)",
        "value": "0.14"
    }
}